Hrabé de Angelis M, Dannhorn D R, Hänel H, Kirchner C
Fachbereich Biologie, Universität Marburg, Fed. Rep. of Germany.
Arzneimittelforschung. 1994 May;44(5):674-8.
The effect of rilopirox (Hoe 351, CAS 104153-37-9) on rabbit blastocysts in vitro was studied. Blastocysts of day 6 post coitum were cultured in Ham's F 10 medium supplemented with polyvinylpyrrolidone using different concentrations of rilopirox with and without serum proteins. In culture conditions without serum proteins there were no differences in the growth rates of the blastocysts after 24 h of culture in the presence of 1 microgram/ml of rilopirox. However, 5 micrograms/ml of rilopirox resulted in a significant reduction of the mean growth rate as well as in a serious morphological damage of the treated blastocysts. Purified human serum albumin could partly prevent this toxic effect, while complete human serum and foetal calf serum did not show this characteristic. Analyses of the protein synthesis of the blastocysts treated with rilopirox by two-dimensional gel electrophoresis and subsequent fluorography did not show any differences in comparison to the untreated controls, despite of obvious morphological alterations.
研究了利洛吡咯(Hoe 351,CAS 104153 - 37 - 9)对兔体外囊胚的影响。在含有聚乙烯吡咯烷酮的Ham's F 10培养基中,使用不同浓度的利洛吡咯,在有和无血清蛋白的情况下培养交配后第6天的囊胚。在无血清蛋白的培养条件下,在存在1微克/毫升利洛吡咯的情况下培养24小时后,囊胚的生长速率没有差异。然而,5微克/毫升的利洛吡咯导致平均生长速率显著降低,以及处理后的囊胚出现严重的形态损伤。纯化的人血清白蛋白可部分预防这种毒性作用,而完整的人血清和胎牛血清则没有这种特性。通过二维凝胶电泳和随后的荧光自显影分析利洛吡咯处理的囊胚的蛋白质合成,尽管有明显的形态改变,但与未处理的对照相比没有显示出任何差异。